Labshake search

1 - 5 of 5 citations for Recombinant Human CD200 Fc tagged since 2019

• A pharmacological toolkit for human microglia identifies Topoisomerase I inhibitors as immunomodulators for Alzheimer’s disease

  Verena Haage, et al., bioRxiv - Neuroscience 2024

  Quote: ... 100 ng/mL CD200 (Bon Opus Biosciences) and 100 ng/mL CX3CL1 (R&D Systems ...
• Resolving the Interactions between Class 3 Semaphorin Receptors in Live Cells

  Shaun M. Christie, et al., bioRxiv - Biophysics 2021

  Quote: ... Recombinant human Semaphorin 3A (CX65, Bon Opus Biosciences, Milburn, NJ) contains residues 21-771 and is >95% pure ...
• Resolving the Interactions between Class 3 Semaphorin Receptors in Live Cells

  Shaun M. Christie, et al., bioRxiv - Biophysics 2021

  Quote: ... Recombinant human Semaphorin 3C (C636, Bon Opus Biosciences, Milburn, NJ) contains residues 21-738 and is >95% pure ...
• A loss-of-function mutation in IL-17F enhances susceptibility of mice to oropharyngeal candidiasis

  Chunsheng Zhou, et al., bioRxiv - Immunology 2020

  Quote: ... Recombinant IL-17F.S65L and IL-17F were synthesized by Bon Opus Biosciences (Millburn, NJ) by expression in Expi293 cells (ThermoFisher) ...
• Th2 and Th17-Associated Immunopathology Following SARS-CoV-2 Breakthrough Infection in Spike-Vaccinated ACE2-humanized Mice

  Tianyi Zhang, et al., bioRxiv - Immunology 2023

  Quote: ... day 0 and day 21) with 5 μg/dose of recombinant SARS-CoV-2 Spike protein (S1+S2 extracellular domain) (Bon Opus Biosciences, #BP040) adjuvanted with 100 μg/dose alhydrogel adjuvant 2% (InvivoGen ...